Across TCGA pan-cancer cohorts, TCEAL9 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TCEAL9 data layer compared with 24 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher TCEAL9 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TCEAL9 expression acts as an unfavorable survival marker.

COAD, ESCA, and SKCM are the cancer types where TCEAL9 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.111	0.871	<.001	12	view →
ESCA	OS	Median	II,III,IV	0.321	0.685	.035	6	view →
SKCM	DFS	Median	All	0.023	0.729	<.001	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: TCEAL9 tumor-vs-normal RNA expression · all TCEAL9 data types